Skip to main content
. 2013 Mar 6;5:45–56. doi: 10.2147/CLEP.S41835

Table 1.

Completeness and correctness of data by selected variables in the Aarhus Sarcoma Registry

Variables Completeness of data % (95% CI), n
Correct data % (95% CI), n
Prevalidation Postvalidation Prevalidation
Date of admission 81.8 (79.7–83.8) 100.0 (99.8–100.0) 43.2 (40.4–46.1)
1180/1442 1827/1827 510/1180
Duration of symptoms 88.1 (86.3–89.7) 95.9 (94.9–96.8) 50.2 (47.4–53.0)
1270/1442 1752/1827 638/1270
Cause of referral 81.1 (78.9–83.1) 100.0 (99.8–100.0) 93.7 (92.1–95.0)
1169/1442 1827/1827 1095/1169
Tumor size 79.1 (76.9–81.2) 95.5 (94.4–96.4) 42.7 (39.8–45.6)
1141/1442 1744/1827 487/1141
Anatomic localization
  Bone sarcoma 77.6 (72.3–81.7) 100.0 (99.3–100.0) 94.1 (90.7–96.5)
287/370 552/552 270/287
  Soft tissue sarcoma 81.8 (79.4–84.1) 100.0 (99.7–100.0) 86.1 (83.6–88.3)
877/1072 1275/1275 755/877
Compartmental localization 79.3 (77.1–81.3) 100.0 (99.8–100.0) 73.0 (70.3–75.5)
1143/1442 1827/1827 834/1143
Histological subtype
  Bone sarcoma 77.8 (73.3–82.0) 100.0 (99.3–100.0) 64.2 (58.4–69.8)
288/370 552/552 185/288
  Soft tissue sarcoma 81.0 (78.5–83.3) 100.0 (99.7–100.0) 79.4 (76.5–82.0)
868/1072 1275/1275 689/868
Grade of malignancy 95.6 (94.4–96.6) 100.0 (99.8–100.0) 53.4 (50.7–56.1)
1378/1442 1827/1827 736/1378
Surgerya
  Date 68.1 (65.5–70.6) 100.0 (99.8–100.0) 25.3 (22.4–28.2)
895/1315 1564/1564 226/895
  Type 80.7 (78.4–82.8) 100.0 (99.8–100.0) 97.7 (96.7–98.5)
1061/1315 1564/1564 1037/1061
  Margin 79.9 (77.7–82.1) 99.9 (99.6–100.0) 76.0 (73.3–78.6)
1051/1315 1563/1564 799/1051
Radiotherapyb 95.6 (94.4–96.6) 100.0 (99.8–100.0) 90.5 (88.8–92.0)
1379/1442 1827/1827 1248/1379
Chemotherapyb 95.6 (94.4–96.6) 100.0 (99.8–100.0) 95.9 (94.8–96.9)
1379/1442 1827/1827 1323/1379

Notes:

a

Subgroup includes only patients treated with surgery (prevalidation, n = 1315; postvalidation, n = 1564);

b

data on whether or not the patient was treated with radiotherapy and chemotherapy.

Abbreviation: CI, confidence interval.